Why HIV Vaccines May Be Failing | |
 | When a vaccine increases the number of immune cells, it may also increase the number of targets for the virus, causing a "backfire effect." |
CDC Analysis Puts Numbers on Condom Effectiveness for Gay Men | |
 | Consistent condom use during anal sex prevented 70% of HIV infections among men who have sex with men. |
Smoking Lowers Life Expectancy More Than HIV Itself | |
HIV-positive smokers lose on average eight more years of life compared to nonsmokers. |  |
What Does 2015 Hold in Store for HIV Research? | |
We asked some of the leading HIV experts what research they're most looking forward to over the next year. |  |
An interview series exploring key issues in HIV care.
Key Issues Affecting the Care of HIV-Positive Adolescents
An Interview With John Steever, M.D.
Unraveling the Impact of Trauma on People With HIV -- and Their Care Providers
An Interview With Edward Machtinger, M.D.
The Future of HIV Prevention, Treatment and Care
An Interview With Mark Harrington
New HIV Heart Disease Findings Not as Dire as They May Seem
An Interview With David Alain Wohl, M.D.
How to Make HIV "Take Up Knitting"
An Interview With David Harrich, Ph.D.
A blog featuring professionals on the frontlines of HIV treatment, prevention and care.
To Russia (and Eastern Europe and Central Asia), With Love
A Blog Entry by Benjamin Young, M.D., Ph.D.
The Cynical Connectedness of Gilead's Hepatitis C Pricing and Anti-Diversion Policies
A Blog Entry by Brook K. Baker
New HCV Option Effective, Safe, Well-Tolerated -- and Use Will Likely Be Driven by Payors
A Blog Entry by Paul E. Sax, M.D.
5 ID/HIV Things to Be Grateful for This Holiday Season, 2014 Edition
A Blog Entry by Paul E. Sax, M.D.
Why the IPERGAY (Yes, That's Its Name) Study Could Substantially Increase Use of PrEP
A Blog Entry by Paul E. Sax, M.D.
Gilead Licenses Generic Version of Improved Sovaldi in India, Agrees to Sovaldi Discount in Germany
Prezcobix, New Once-Daily HIV Drug, Approved by FDA
Evotaz, New Once-Daily HIV Drug, Approved by FDA
Analysis Linking Depo-Provera to HIV Risk Deepens Debate on the Injectable Contraceptive
Hepatitis C Drug Victrelis (Boceprevir) Gets Pulled by Manufacturer
Antiretroviral Neurotoxicity May Cause Cognitive Problems
Can Statins Help to Reduce the Risk of Cancer?
General Risk Factors for Premature Births
Statins: Overall Many Benefits and a Few Risks
Antiretroviral Therapy During Pregnancy Found Safe for Babies' Hearts
TheBodyPRO.com: About TheBodyPRO.com | Contact TheBodyPRO.com | Content Policy | Advertise With Us
Remedy Health Media: About Remedy Health Media | Contact Remedy Health Media | Terms of Use | Privacy Policy
TheBodyPRO.com is a service of Remedy Health Media, LLC, 750 3rd Avenue, 6th Floor, New York, NY 10017. TheBodyPRO.com and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of TheBodyPRO.com's homepage, topic pages, page designs and HTML code. General Disclaimer: TheBodyPRO.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBodyPRO.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.
